US Stock MarketDetailed Quotes
FGEN FibroGen
- 0.425
- +0.036+9.18%
Close Nov 29 13:00 ET
- 0.423
- -0.001-0.31%
Post 17:01 ET
42.80MMarket Cap-345P/E (TTM)
0.433High0.381Low1.09MVolume0.397Open0.389Pre Close442.24KTurnover1.17%Turnover RatioLossP/E (Static)100.77MShares2.93052wk High-0.18P/B39.51MFloat Cap0.18052wk Low--Dividend TTM93.03MShs Float68.550Historical High--Div YieldTTM13.32%Amplitude0.180Historical Low0.405Avg Price1Lot Size
About FibroGen Company
FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993, and is headquartered in San Francisco, CA.
Company Profile
SymbolFGEN
Company NameFibroGen
Listing DateNov 14, 2014
Issue Price18.00
Founded1993
CEOMr. Thane Wettig
MarketNASDAQ
Employees486
Fiscal Year Ends12-31
Address350 Bay Street,Suite 100-6009
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94133
Phone1-415-978-1200
Websitehttp://www.fibrogen.com
Company Executives
- Name
- Position
- Salary
- Thane Wettig
- Chief Executive Officer and Director
- 3.64M
- Juan Graham
- Chief Financial Officer and Principal Accounting Officer
- 3.09M
- Christine Chung
- Senior Vice President, China Operations
- 3.11M
- James A. Schoeneck
- Chairman of the Board
- 499.58K
- Jeffrey L. Edwards
- Independent Director
- 385.53K
- Dr. Aoife M. Brennan, M.B.
- Independent Director
- 373.03K
- Jeffrey W. Henderson
- Independent Director
- 370.53K
- Dr. Maykin Ho, PhD
- Independent Director
- 375.53K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data